Emergen Research Logo

Rising incidence of epilepsy and psychiatric disorders is a key factor driving anticonvulsants market revenue growth

VANCOUVER, BC, CANADA, January 18, 2023 /EINPresswire.com/ -- The global anticonvulsants market size was USD 18.16 Billion in 2021 and is expected to register a revenue CAGR of 2.3% during the forecast period, according to latest analysis by Emergen Research. Rising high-value investments in the healthcare sector along with increasing Research & Development (R&D) initiative by various major pharmaceutical companies for improvement in anticonvulsant therapy tolerability and drugs are major factors driving market revenue growth. In addition, rising incidences of epilepsy and various neurological disorders along with growing need for pain management caused by migraines are contributing to growth of the anticonvulsants market.

Moreover, the Anticonvulsants Market report provides even handed, objective estimation and analysis of prospects in the Anticonvulsants Market with systematic market study report containing several other market vital factors. This qualified industry analyst evaluates the cost, market share, growth opportunities, technologies, market sizing, supply chains, applications, export & import, companies, and so on, with the sole effort of assisting our clients to make well-read business decisions.

For In depth Information Get Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1213

The report Anticonvulsants Market conveys a serious viewpoint covering worldwide market refreshes, future development, business possibilities, impending turns of events, and future ventures. Besides, the report perceives the top organizations alongside their advertising system, organization profile, most recent progressions, business strategies, item portfolios, market techniques, sales value, volume, limit, and cost structure. Global Anticonvulsants Market has increased with a healthy growth rate over the years and is expected to increase further during the forecasted period.

Key Players Profiled in the Report are:

GSK Group of Companies, Novartis AG, Pfizer Inc., UCB S.A, Johnson & Johnson Services, Inc., Abbott, Sunovion Pharmaceuticals Inc., Jazz Pharmaceuticals, Inc., Eisai Co., Ltd., and Sanofi.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/1213

Some Key Highlights

The AMPA segment accounted for largest revenue share in 2021. AMPA is utilized in treatment of partial on-set seizures in patients suffering from epilepsy as drugs bind to AMPA receptor present in Central Nervous System (CNS) and block the receptor, which is one of the key factors driving revenue growth of this segment. Two major subtypes of AMPARs, calcium-permeable (CP-AMPARs) and calcium-impermeable (CI-AMPARs) offer different roles in the maintenance of balance in excitation-inhibition of brain.

Better efficacy, fewer side effects, and greater tolerance of second-generation anticonvulsant medications are major factors driving revenue growth of this segment. Moreover, non-requirement of blood level monitoring is increasing demand for second-generation drugs. High demand for anticonvulsant drugs for monotherapy or supplementary therapy is contributing to growth of this segment as well.

The hospital pharmacies segment accounted for a significant revenue share in 2021. Increasing number of hospital pharmacies for neurological disorder, in addition to presence of doctors and medical professionals in both developed as well as emerging countries, are a few key factors driving revenue growth of this segment. Increasing healthcare infrastructure with proper medical supplies and facilities along with high-value funding for development of innovative drugs are contributing to growth of this segment.

Furthermore, the report provides a comprehensive overview of the Anticonvulsants market along with product portfolio and market performance. The report offers key insights into market share, supply chain analysis, demand and supply ratio, import/export details, and product and consumption patterns. To gain a better understanding, the report is further segmented into sections such as product types offered by the market, application spectrum, companies, and key geographical regions where the market has established its presence.

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/anticonvulsants-market

Emergen Research has segmented the global anticonvulsants market based on drug type, drug generation, distribution channel, and region:

Drug Type Outlook (Revenue, USD Billion; 2019-2030)

α-Amino-3-Hydroxy-5-Methyl-4-isoxazolepropionic Acid (AMPA)

N-Methyl-D-Aspartate Receptor (NMDAR)

Carbamate Anticonvulsants

Barbiturate

Carbonic Anhydrase Inhibitor

Triazine

Others

Drug Generation Outlook (Revenue, USD Billion; 2019-2030)

First Generation

Second Generation

Third Generation

Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)

Online Pharmacies

Retail Pharmacies

Hospital Pharmacies

Analysis of the segments and their growth projection is carried out by extensive historical and current analysis of the market scenario. Further, the report offers details about the factors and features of the Anticonvulsants market expected to boost the growth of the industry in the coming years.

Research Coverage:

The market research covers all sectors of the Anticonvulsants Market. Its goal is to determine the market’s size and growth potential across several areas, such as application, vertical, and geography. It contains a detailed competition analysis of the market’s major competitors, as well as company profiles, significant insights about product and business offerings, recent developments, and key market strategies.

Key Questions Answered in the Report:

What is the growth rate of the Anticonvulsants market? What is the anticipated market valuation of Anticonvulsants industry by 2030?

What are the key growth driving and restraining factors of the Anticonvulsants market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

What are the key opportunities and growth prospects of the Anticonvulsants industry over the forecast period?

Which region is expected to show significant growth in the coming years?

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/1213

Thank you for reading our report. Please connect with us to know more about the report or for requesting the customization of the report. Our team will ensure the report is best suited to your requirements.

Look Over transcripts provided by Emergen Research

Minimal Residual Disease Market

https://www.emergenresearch.com/industry-report/minimal-residual-disease-market

adas and autonomous driving components market

https://www.emergenresearch.com/industry-report/adas-and-autonomous-driving-components-market

biometrics market

https://www.emergenresearch.com/industry-report/biometrics-market

adaptive cruise control market

https://www.emergenresearch.com/industry-report/adaptive-cruise-control-market

specialty enzymes market

https://www.emergenresearch.com/industry-report/specialty-enzymes-market

power monitoring market

https://www.emergenresearch.com/industry-report/power-monitoring-market

iot connectivity market

https://www.emergenresearch.com/industry-report/iot-connectivity-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn

The global anticonvulsants market size was USD 18.16 Billion in 2021 and is expected to register a revenue CAGR of 2.3%

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.